Health Condition 1: K582- Mixed irritable bowel syndrome
Conditions
Interventions
Intervention1: Terminalia Chebula 30C: The Medicine Will Be Administered In Potentized Form In 30C Potency And The Route Of Administration Will Be Oral And At Baseline The Medicine Will Be Given As 4
Sponsors
National Institute Of Homoeopathy Delhi
Eligibility
Inclusion criteria
Inclusion criteria: Age group 18 to 50 years of both sexes Patients diagnosed with irritable bowel syndrome IBS as per Rome IV criteria 2016 Patients willing to participate by providing written informed consent
Exclusion criteria
Exclusion criteria: Patient associated with any other chronic and advanced systemic disease like uncontrolled Diabetes Mellitus Severe Hypertension Immunocompromised and Malignancy Patient taking treatment from any other system of medicine for same complaint Pregnant or lactating women Family history of colon cancer rectal bleeding age more than 50 years weight loss psychiatric conditions Any type of severe complication like fecal impaction rectal prolapse bowel leakage or surgical cases Patients with known hypersensitivity or allergy to Terminalia chebula or other Homoeopathic Medicine Systemic illness that required hospital admission Participation in any other clinical study during the study period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IRRITABLE BOWEL SYNDROME SYMPTOM SEVERITY SCALE (IBS- SSS)Timepoint: Assessed At Baseline And After 3 Months Of Intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Manju Kumari
National Institute Of Homoeopathy Delhi
Outcome results
None listed